The establishment of new therapeutic strategy for bladder cancer targeting to cancer stem cell
The establishment of new therapeutic strategy for bladder cancer targeting to cancer stem cell
批准号:
17K16812
负责人:
Ogihara Koichiro
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2017
资助国家:
日本
项目状态:
已结题
起止时间:
2017-04-01 至 2019-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The establishment of new therapeutic strategy for metastatic urothelial carcinoma targeting to cancer stem cell
建立针对癌症干细胞的转移性尿路上皮癌治疗新策略
DOI:
--
发表时间:
2018
期刊:
影响因子:
--
作者:
[Ogihara Koichiro, Kikuchi Eiji, Okazaki Shogo, Hagiwara Masayuki, Takeda Toshikazu, Kosaka Takeo, Mikami Shuji, Saya Hideyuki, Oya Mototsugu]
通讯作者:
Oya Mototsugu
The effect of sulfasalazine on bladder cancer stem like cells targeting to cystine transporter
柳氮磺吡啶对靶向胱氨酸转运蛋白的膀胱癌干细胞样细胞的影响
DOI:
--
发表时间:
2017
期刊:
影响因子:
--
作者:
[Ogihara Koichiro, Kikuchi Eiji, Okazaki Shogo, Hagiwara Masayuki, Takeda Toshikazu, Kosaka Takeo, Mikami Shuji, Saya Hideyuki, Oya Mototsugu, Koichiro Ogihara, 荻原 広一郎]
通讯作者:
荻原 広一郎
CD44 variant 9 expression is a novel indicator for identifying poor survival in patients with invasive urothelial carcinoma
CD44 变体 9 表达是识别浸润性尿路上皮癌患者生存不良的新指标
DOI:
--
发表时间:
2019
期刊:
影响因子:
--
作者:
[Ogihara Koichiro, Kikuchi Eiji, Hagiwara Masayuki, Matsumoto Kazuhiro, Mikami Shuji, Saya Hideyuki, Oya Mototsugu]
通讯作者:
Oya Mototsugu
The therapeutic effect of sulfasalazine for metastatic urothelial carcinoma targeting to cancer stem cell
柳氮磺吡啶靶向肿瘤干细胞治疗转移性尿路上皮癌的疗效
DOI:
--
发表时间:
2018
期刊:
影响因子:
--
作者:
[Ogihara Koichiro, Kikuchi Eiji, Takeda Toshikazu, Kosaka Takeo, Saya Hideyuki, Oya Mototsugu]
通讯作者:
Oya Mototsugu
The establishment of new therapeutic strategy for metastatic urothelial carcinoma targeting to cancer stem cell.
建立针对癌症干细胞的转移性尿路上皮癌新治疗策略。
DOI:
--
发表时间:
2018
期刊:
影响因子:
--
作者:
[Ogihara Koichiro, Kikuchi Eiji, Okazaki Shogo, Hagiwara Masayuki, Takeda Toshikazu, Kosaka Takeo, Mikami Shuji, Saya Hideyuki, Oya Mototsugu, Koichiro Ogihara]
通讯作者:
Koichiro Ogihara
Establishing New Therapeutic Strategy for Urothelial Carcinoma
-
批准号:21K16757
-
项目类别:Grant-in-Aid for Early-Career Scientists
-
资助金额:$2.91万
-
财政年份:2021
-
负责人:Ogihara Koichiro
-
依托单位:
海外基金